<DOC>
	<DOC>NCT01106287</DOC>
	<brief_summary>This study will evaluate the safety and tolerability of single doses of MK-0941 based on assessment of clinical and laboratory adverse experiences</brief_summary>
	<brief_title>Single Doses of MK-0941 in Type 2 Diabetics (MK-0941-027)</brief_title>
	<detailed_description />
	<criteria>Female participants of reproductive potential must test negative for pregnancy and agree to use two acceptable methods of birth control Diagnosis of Type 2 Diabetes and is either being treated with diet and exercise alone or with a single or combination oral antihyperglycemic agent No treatment with three of more antihyperglycemic agents or any treatment regimen that includes insulin In good health (except for Type 2 Diabetes) Willingness to follow a specific diet throughout the study (consisting of 50% carbohydrates, 20%protein and 30% fat) Nonsmoker History of stroke, chronic seizure or major neurological disorder History of cancer History of Type 1 Diabetes Recent history of eye infection Glaucoma or blindness Eye surgery (by incision or laser) within the past three months</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>